EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Medicinal Chemistry Strategies for Targeting RNA-Binding Proteins: Design, Optimization, and Therapeutic Potential

Bangbang Li, Hao Shen, Zeliang Xu, Yixi Wang, Jiayu Ding, Zhongrui Shi, Chengliang Sun, Peng Yang iD, Xiao Wang iD

Journal of Medicinal Chemistry · 12.11.2026 · 69 (21) · 25012-25040

DOI: 10.1021/acs.jmedchem.6c02201 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Medicinal Chemistry, online erschienen am 14.10.2026. Verfasst von Bangbang Li und 8 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing211198, China. Hauptthemen laut MEDLINE: RNA-Binding Proteins, Drug Design, Neoplasms, Antineoplastic Agents. Die Arbeit nennt 173 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Xinjiang Uygur Autonomous Region of China, Ministry of Education of the People's Republic of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

RNA-binding proteins (RBPs) are essential regulators of post-transcriptional gene expression whose disruption contributes broadly to tumor initiation, progression, and therapeutic resistance. Through their control of RNA splicing, stability, translation, and epitranscriptomic modification, these proteins orchestrate oncogenic networks that sustain hallmark cancer phenotypes. This central role has stimulated intensive efforts to develop small-molecule RBP inhibitors, yielding mechanistically diverse compounds against m6A pathway components and classical oncogenic RBPs with demonstrated efficacy in preclinical models. However, substantial challenges remain, including achieving high target selectivity, optimizing drug-like properties, and addressing adaptive resistance mechanisms. This article examines recent advances in RBP-targeted therapeutics, highlighting design strategies, structural mechanisms, and key obstacles on the path toward clinical application.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RNA-Binding ProteinsDrug DesignNeoplasmsAntineoplastic AgentsSmall Molecule LibrariesHumansAnimalsChemistry, Pharmaceutical

Stichwörter der Autor:innen

RNA-binding proteinscancer therapydrug discoverysmall-molecule inhibitors

Substanzen

RNA-Binding ProteinsAntineoplastic AgentsSmall Molecule Libraries

Autor:innen und Institutionen

  • State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing211198, China.
  • Department of Medicinal Chemistry, School of Pharmacy, China Pharmaceutical University, Nanjing211198, China.
  • Institute of Innovative Drug, China Pharmaceutical University, Nanjing211198, China.

ORCID-Profile: Peng Yang, Xiao Wang

Förderung

  • National Natural Science Foundation of China
  • Xinjiang Uygur Autonomous Region of China
  • Ministry of Education of the People's Republic of China
  • State Key Laboratory of Natural Medicines

Zitieren

APA

Li, B., Shen, H., Xu, Z., Wang, Y., Ding, J., Shi, Z., Sun, C., Yang, P., & Wang, X. (2026). Medicinal Chemistry Strategies for Targeting RNA-Binding Proteins: Design, Optimization, and Therapeutic Potential. Journal of Medicinal Chemistry, 69(21), 25012-25040. https://doi.org/10.1021/acs.jmedchem.6c02201

Vancouver

Li B, Shen H, Xu Z, Wang Y, Ding J, Shi Z, et al. Medicinal Chemistry Strategies for Targeting RNA-Binding Proteins: Design, Optimization, and Therapeutic Potential. Journal of Medicinal Chemistry. 2026;69(21):25012-25040. doi:10.1021/acs.jmedchem.6c02201

BibTeX
@article{Li2026,
  author = {Li, Bangbang and Shen, Hao and Xu, Zeliang and Wang, Yixi and Ding, Jiayu and Shi, Zhongrui and Sun, Chengliang and Yang, Peng and Wang, Xiao},
  title = {Medicinal Chemistry Strategies for Targeting RNA-Binding Proteins: Design, Optimization, and Therapeutic Potential},
  journal = {Journal of Medicinal Chemistry},
  year = {2026},
  volume = {69},
  number = {21},
  pages = {25012--25040},
  doi = {10.1021/acs.jmedchem.6c02201}
}
Kostenlos starten →